Ginkgo Bioworks Holdings Inc (DNA) recent activity suggests a positive outlook with the last week’s performance of -12.68%

On Friday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) opened lower -7.23% from the last session, before settling in for the closing price of $13.14. Price fluctuations for DNA have ranged from $5.00 to $16.85 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has dropped its sales by -27.97% annually for the last half of the decade. Company’s average yearly earnings per share was noted 41.87% at the time writing. With a float of $39.91 million, this company’s outstanding shares have now reached $43.08 million.

In an organization with 834 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 73.59%, operating margin of -198.27%, and the pretax margin is -199.02%.

Ginkgo Bioworks Holdings Inc (DNA) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ginkgo Bioworks Holdings Inc is 31.29%, while institutional ownership is 57.35%. The most recent insider transaction that took place on Jul 17 ’25, was worth 10,669. In this transaction an insider of this company sold 1,084 shares at a rate of $9.84, taking the stock ownership to the 10,679 shares. Before that another transaction happened on Jul 17 ’25, when Company’s Officer proposed sale 640 for $9.84, making the entire transaction worth $6,299.

Ginkgo Bioworks Holdings Inc (DNA) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 41.87% per share during the next fiscal year.

Ginkgo Bioworks Holdings Inc (NYSE: DNA) Trading Performance Indicators

Check out the current performance indicators for Ginkgo Bioworks Holdings Inc (DNA). In the past quarter, the stock posted a quick ratio of 4.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.01.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.99, a number that is poised to hit -1.57 in the next quarter and is forecasted to reach -4.86 in one year’s time.

Technical Analysis of Ginkgo Bioworks Holdings Inc (DNA)

Let’s dig in a bit further. During the last 5-days, its volume was 1.32 million. That was inferior than the volume of 1.52 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 43.39%.

During the past 100 days, Ginkgo Bioworks Holdings Inc’s (DNA) raw stochastic average was set at 68.61%, which indicates a significant increase from 47.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.15 in the past 14 days, which was higher than the 0.73 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $9.92, while its 200-day Moving Average is $9.21. However, in the short run, Ginkgo Bioworks Holdings Inc’s stock first resistance to watch stands at $12.58. Second resistance stands at $12.96. The third major resistance level sits at $13.38. If the price goes on to break the first support level at $11.78, it is likely to go to the next support level at $11.36. The third support level lies at $10.98 if the price breaches the second support level.

Ginkgo Bioworks Holdings Inc (NYSE: DNA) Key Stats

There are currently 58,532K shares outstanding in the company with a market cap of 713.50 million. Presently, the company’s annual sales total 227,040 K according to its annual income of -547,030 K. Last quarter, the company’s sales amounted to 48,320 K and its income totaled -90,960 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.